Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Noritsu Koki, The Current Fiscal Year Net Income Revised Downward by 9%
7744 Noritsu Koki Co.,Ltd. 【IFRS】
Earnings ReportNoritsu Koki Co.,Ltd. <7744> [TSE Prime] announced its financial results (based on IFRS) after the market closed on May 9th (15:30). The consolidated net income for the first quarter of the fiscal year ending December 2025 (January to March) dropped 46.2% from the same period last year to 2.81 billion yen.
In addition, the full-year consolidated net income has decreased 8.5%, from the previous forecast of 11.7 billion yen to 10.7 billion yen (compared to 16.1 billion yen in the previous period), leading to an increase in the profit decline rate from 27.4% to 33.6%.
Furthermore, the January to June period (1H) consolidated net income forecast remains unchanged from the estimate of 5.4 billion yen(compared to 11.4 billion yen in the previous period).
In the most recent three-month period, from January to March (1Q), the operating profit margin significantly dropped from 28.3% in the same period last year to 15.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2023 | 17,398 | 2,020 | 1,825 | 1,051 | 9.8 | 25.4 | May 12, 2023 | IFRS |
| Jan - Mar, 2024 | 26,922 | 7,627 | 7,646 | 5,235 | 48.9 | 54.2 | May 10, 2024 | IFRS |
| Jan - Mar, 2025 | 27,200 | 4,315 | 4,372 | 2,814 | 26.3 | 55.3 | May 9, 2025 | IFRS |
| YoY | +1.0% | -43.4% | -42.8% | -46.2% | -46.2% |
Guidance Update
First Half Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 Prev | 52,500 | 8,000 | 7,900 | 5,400 | 50.9 | 36.67 | Feb 14, 2025 | IFRS |
| Jan - Jun, 2025 New | 51,300 | 8,000 | 7,900 | 5,400 | 50.9 | 36.67 | May 9, 2025 | IFRS |
| Revision Rate | -2.3% | 0.0% | 0.0% | 0.0% | 0.0% |
Full Year Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Prev | 112,600 | 17,400 | 17,100 | 11,700 | 110.4 | 73.67 | Feb 14, 2025 | IFRS |
| Dec, 2025 New | 110,700 | 16,000 | 15,700 | 10,700 | 100.9 | 73.67 | May 9, 2025 | IFRS |
| Revision Rate | -1.7% | -8.0% | -8.2% | -8.5% | -8.5% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2024 | 52,763 | 12,413 | 14,107 | 11,484 | 107.3 | 19.33 | Aug 9, 2024 | IFRS |
| Jan - Jun, 2025 Guidance | 51,300 | 8,000 | 7,900 | 5,400 | 50.9 | 36.67 | May 9, 2025 | IFRS |
| YoY | -2.8% | -35.6% | -44.0% | -53.0% | -52.5% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 90,052 | 14,388 | 13,677 | 10,199 | 95.3 | 38.33 | Feb 13, 2024 | IFRS |
| Dec, 2024 | 106,539 | 20,507 | 20,437 | 16,120 | 150.5 | 60.33 | Feb 14, 2025 | IFRS |
| Dec, 2025 Guidance | 110,700 | 16,000 | 15,700 | 10,700 | 100.9 | 73.67 | May 9, 2025 | IFRS |
| YoY | +3.9% | -22.0% | -23.2% | -33.6% | -33.0% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 26,922 | 7,627 | 7,646 | 5,235 | 48.9 | 28.3 | May 10, 2024 | IFRS |
| Apr - Jun, 2024 | 25,841 | 4,786 | 6,461 | 6,249 | 58.4 | 18.5 | Aug 9, 2024 | IFRS |
| Jul - Sep, 2024 | 25,674 | 4,295 | 2,082 | 1,431 | 13.4 | 16.7 | Nov 8, 2024 | IFRS |
| Oct - Dec, 2024 | 28,102 | 3,799 | 4,248 | 3,205 | 29.9 | 13.5 | Feb 14, 2025 | IFRS |
| Jan - Mar, 2025 | 27,200 | 4,315 | 4,372 | 2,814 | 26.3 | 15.9 | May 9, 2025 | IFRS |
| YoY | +1.0% | -43.4% | -42.8% | -46.2% | -46.2% |
Related Articles
HIRAKAWA HEWTECH, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 21% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
KOSE, Jan-Mar (1Q) Ordinary Profit Decreases by 50%
SHIMA SEIKI MFG, Returning to Profitability This Year, Dividend Raised by 10 yen
AUTOBACS SEVEN, 8% Increase in Ordinary Profit for The Current Fiscal Year
SUSMED, Jul-Mar (Cumulative 3Q) Ordinary Profit Loss Narrows, Jan-Mar Ordinary Profit Turns to Profit
Business Coach, The Current Fiscal Year Ordinary Profit Revised Upward by 53%
ATOM, Returning to Profitability This Year
Sekisui Plastics, 14 times Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 7 yen
Sumitomo Metal Mining, 3.5 times Increase in Net Income for The Current Fiscal Year, Dividend Raised by 27 yen
BrightPath Biotherapeutics, Continue Net Income Turns to Loss